Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease
Not Applicable
- Conditions
- ICD: U07.1: SARS-CoV-2U07.1COVID-19, virus identified
- Registration Number
- DRKS00021214
- Lead Sponsor
- Klinik für Innere Medizin I (UKSH Campus Kiel)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
SARS-CoV-2 infection confirmed by laboratory findings; the positive test must not date back more than 7 days.
Relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract.
The patient has been able to give written consent via a website before any trial procedure is performed and can comply with the trial-dependent prerequisites and requirements.
Exclusion Criteria
Current participation in another trial.
Pregnancy or breastfeeding.
Vaccination against SARS-CoV-2.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequencies of individual COVID-19 symptoms at week 0, week 2 (primary time of analysis), week 4 and week 6 as well as after 6 months.
- Secondary Outcome Measures
Name Time Method